13F-HR filed by Atle Fund Management AB
Atle Fund Management AB filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-12 12:59:19 UTC, with 39 holding rows worth $373,391,375.
- Accession
- 0001381843-26-000013
- Filer
- CIK 1381843
- Filed
- 2026-11-12
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 39 entries on the cover page, a total value of $373,391,375 stated on the cover page (in dollars after the unit check, H1), rows summing to $373,391,375 with VALUE read as dollars as filed, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 31,202 | $36,103,210 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 168,987 | $24,555,501 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 91,387 | $24,193,794 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 91,294 | $23,881,597 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 34,410 | $23,228,471 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 70,955 | $16,027,315 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 28,157 | $14,720,761 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 66,113 | $13,570,354 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 35,679 | $13,056,373 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 139,311 | $11,937,560 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 36,107 | $10,841,127 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 163,697 | $10,771,263 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 25,648 | $10,429,246 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 87,469 | $9,983,712 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 109,647 | $9,464,729 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 34,296 | $9,444,775 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 77,377 | $9,389,699 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 28,074 | $9,336,289 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 89,251 | $7,701,469 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 303,824 | $7,389,000 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 54,102 | $6,149,233 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 40,461 | $6,030,712 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 70,071 | $5,989,669 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 26,735 | $5,948,538 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 130,622 | $5,701,650 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 136,225 | $5,519,837 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 38,611 | $5,476,584 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 184,394 | $4,600,630 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 46,452 | $4,599,677 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 44,243 | $3,938,954 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 43,180 | $3,596,462 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 93,550 | $3,594,191 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 184,687 | $3,123,057 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 243,506 | $3,029,215 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 43,682 | $2,859,424 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 29,893 | $2,377,091 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 14,924 | $2,058,467 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 663,772 | $1,546,589 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 10,106 | $1,225,150 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001381843-26-000013 | this filing | 2026-11-12 |